Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
National Institutes of Health Nationwide (Federal)
Tell us about your organization and we'll show you whether this grant fits, and why.
Free to start. No credit card required.
Deadline
September 25, 2028
Region
Nationwide (Federal)
Funder type
Federal Government
For
Nonprofits & businesses
Sectors
Health & Human Services
About this program
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) — U.S. federal funding opportunity (PAR-27-026) from National Institutes of Health. See grants.gov for full eligibility and details.
Is this grant worth your time?
Create a free account and Happy Grants scores this program, and 2,300+ others, against your organization’s profile in about a minute, with the reasons explained.
See your match score, freeSimilar grants
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)National Institutes of Health Jun 16, 2028
- BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)National Institutes of Health Feb 8, 2029
- Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)National Institutes of Health Oct 28, 2027
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)National Institutes of Health Jan 7, 2028
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)National Institutes of Health Jan 7, 2028
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)National Institutes of Health Nov 18, 2026